June 1, 2020
The Ministry of Health, Labor and Welfare (MHLW) approved a batch of drugs for their label expansions on May 29, including Nippon Boehringer Ingelheim’s tyrosine kinase inhibitor Ofev (nintedanib) for the treatment of progressive fibrosing interstitial lung disease (PF-ILD). In...read more